Company Telomir Pharmaceuticals, Inc.

TELO

US87975F1049

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 10:27:47 2024-06-11 am EDT			5-day change	1st Jan Change
5.42 ^USD	+0.37%		+2.56%	0.00%

May. 30	Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1	CI
May. 13	Telomir Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Telomir Pharmaceuticals, Inc. is a United States-based company. The Company operates as pre-clinical-stage pharmaceutical company focused on developing TELOMIR-1 small molecule to lengthen the deoxyribonucleic acidâs (DNA) protective telomere caps to affect age reversal. It selectively affects the processes that drive the concentration and accumulation of iron and copper in the serum that affects diseases like hemochromatosis and cancer.

Number of employees: 5

Managers	Title	Age	Since
Christopher Chapman CEO	Chief Executive Officer	71	21-08-25
Nathen Fuentes DFI	Director of Finance/CFO	41	23-09-20
Michelle Yanez AUD	Comptroller/Controller/Auditor	52	22-04-30

Members of the board	Title	Age	Since
Christopher Chapman CEO	Chief Executive Officer	71	21-08-25
Craig Eagle BRD	Director/Board Member	57	22-10-31
Talhia Tuck BRD	Director/Board Member	46	22-10-31
Brad Kroenig BRD	Director/Board Member	45	22-10-31
Hugh McColl BRD	Director/Board Member	63	22-10-31
Michelle Yanez AUD	Comptroller/Controller/Auditor	52	22-04-30
Michael Jerman BRD	Director/Board Member	40	Oct. 31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	29,609,814	17,031,576 ( 57.52 %)	0	57.52 %

Name	Equities	%	Valuation
Brian McNulty 29.54 %	8,748,126	29.54 %	53 M $
Donnell Francis E Jr O 7.157 %	2,119,220	7.157 %	13 M $
Christopher Chapman 3.295 %	975,610	3.295 %	6 M $
Craig Eagle 1.647 %	487,805	1.647 %	3 M $
Nathen Fuentes 0.3416 %	101,134	0.3416 %	611 861 $
Talhia Tuck 0.1647 %	48,781	0.1647 %	295 125 $
Brad Kroenig 0.1647 %	48,781	0.1647 %	295 125 $
Hugh McColl 0.1647 %	48,781	0.1647 %	295 125 $
Suncoast Equity Management LLC 0.0824 %	24,391	0.0824 %	147 566 $
Citigroup Global Markets, Inc. (Investment Management) 0.0599 %	17,748	0.0599 %	107 375 $

Telomir Pharmaceuticals, Inc.

855 North Wolfe Street Suite 601

21205, Baltimore

http://www.telomirpharma.com

address Telomir Pharmaceuticals, Inc.(TELO)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
TELOMIR PHARMACEUTICALS, INC.	0.00%	160M
ELI LILLY AND COMPANY	+48.39%	779B
JOHNSON & JOHNSON	-6.13%	354B
MERCK & CO., INC.	+20.61%	333B
ABBVIE INC.	+10.00%	301B
ASTRAZENECA PLC	+16.98%	249B
ROCHE HOLDING AG	-1.76%	216B
NOVARTIS AG	+11.09%	214B
AMGEN INC.	+5.80%	163B
PFIZER, INC.	-2.50%	159B